Industry Research Reports
Home > Reports > Chemical & Material > Enflurane - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Enflurane - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-06-16
Pages: 111 Pages
Report ld: 4765776
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Enflurane was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Enflurane cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Enflurane is an inhalational anesthetic, belonging to the class of halogenated ethers. It works by inhibiting the central nervous system, rendering patients pain-free and unconscious during surgical procedures. Enflurane is characterized by its rapid onset, strong controllability, and minimal impact on the respiratory and circulatory systems. It is widely used in clinical anesthesia. The market for Enflurane is primarily concentrated in medical institutions and operating rooms. With the advancement of medical technology and the increase in surgical procedures, the demand for Enflurane is also evolving. In recent years, the market share of Enflurane has declined due to the emergence of newer anesthetics. However, it still holds irreplaceable value in specific surgical scenarios. From an industry perspective, the research and development of Enflurane involve not only its pharmacological properties but also its market positioning, competitive landscape, and future development trends.
Market Development Opportunities & Main Driving Factors
The market development opportunities for Enflurane are mainly reflected in several aspects. Firstly, with the increasing global aging population and the growing number of chronic disease patients, the demand for surgeries is also rising, providing a stable market base for Enflurane. Secondly, despite the emergence of new anesthetics, Enflurane still has unique advantages in certain specific surgical scenarios, such as short-duration surgeries and surgeries with lower requirements for respiratory depression. Additionally, the continuous improvement of medical infrastructure and increasing investment in medical resources in developing countries offer new space for the market expansion of Enflurane. These factors collectively drive the continuous development of the Enflurane market.
Market Challenges, Risks, & Restraints
The market for Enflurane also faces numerous challenges and risks. On the one hand, the continuous introduction of new anesthetics has impacted the market share of Enflurane. These new anesthetics may have advantages in terms of safety and side effect control, leading some medical institutions to reduce their use of Enflurane. On the other hand, strict pharmaceutical regulatory policies and environmental requirements have increased the production costs and market access difficulties for Enflurane. Moreover, with intense market competition, companies need to continuously improve their competitiveness in product quality, price, and service to cope with pressure from domestic and international peers.
Downstream Demand Trends
From the perspective of downstream demand trends, the market demand for Enflurane will gradually shift towards refinement and specialization. As medical technology advances and the complexity and precision requirements of surgeries increase, medical institutions will place greater emphasis on the adaptability and safety of anesthetics. In the future, Enflurane is likely to be used more in specific types of surgeries, such as those for elderly patients or in certain specialized departments. Meanwhile, with the development of medical informatization, medical institutions will have more standardized and transparent procurement and usage management of anesthetics, which will also pose higher requirements for the market promotion of Enflurane.
This report aims to provide a comprehensive presentation of the global market for Enflurane, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enflurane by region & country, by Type, and by Application.
The Enflurane market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enflurane.
MARKET SEGMENTATION
By Company
- Baxter
- J&TEC
- GE Healthcare
- Gasera
- Draeger
- Abbott
- AstraZeneca
- Sanofi
- Pfizer
- Johnson & Johnson
- Merck
- Roche
- Novartis
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pharmaceutical Grade Enflurane
- Industrial Grade Enflurane
Segment by Application
- Medicine
- Chemical Industry
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Enflurane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Enflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Enflurane in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Enflurane Product Introduction
1.2 Global Enflurane Market Size Forecast
1.2.1 Global Enflurane Sales Value (2020-2031)
1.2.2 Global Enflurane Sales Volume (2020-2031)
1.2.3 Global Enflurane Sales Price (2020-2031)
1.3 Enflurane Market Trends & Drivers
1.3.1 Enflurane Industry Trends
1.3.2 Enflurane Market Drivers & Opportunity
1.3.3 Enflurane Market Challenges
1.3.4 Enflurane Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Enflurane Players Revenue Ranking (2024)
2.2 Global Enflurane Revenue by Company (2020-2025)
2.3 Global Enflurane Players Sales Volume Ranking (2024)
2.4 Global Enflurane Sales Volume by Company Players (2020-2025)
2.5 Global Enflurane Average Price by Company (2020-2025)
2.6 Key Manufacturers Enflurane Manufacturing Base and Headquarters
2.7 Key Manufacturers Enflurane Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Enflurane
2.9 Enflurane Market Competitive Analysis
2.9.1 Enflurane Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Enflurane Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enflurane as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pharmaceutical Grade Enflurane
3.1.2 Industrial Grade Enflurane
3.2 Global Enflurane Sales Value by Type
3.2.1 Global Enflurane Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Enflurane Sales Value, by Type (2020-2031)
3.2.3 Global Enflurane Sales Value, by Type (%) (2020-2031)
3.3 Global Enflurane Sales Volume by Type
3.3.1 Global Enflurane Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Enflurane Sales Volume, by Type (2020-2031)
3.3.3 Global Enflurane Sales Volume, by Type (%) (2020-2031)
3.4 Global Enflurane Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medicine
4.1.2 Chemical Industry
4.1.3 Others
4.2 Global Enflurane Sales Value by Application
4.2.1 Global Enflurane Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Enflurane Sales Value, by Application (2020-2031)
4.2.3 Global Enflurane Sales Value, by Application (%) (2020-2031)
4.3 Global Enflurane Sales Volume by Application
4.3.1 Global Enflurane Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Enflurane Sales Volume, by Application (2020-2031)
4.3.3 Global Enflurane Sales Volume, by Application (%) (2020-2031)
4.4 Global Enflurane Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Enflurane Sales Value by Region
5.1.1 Global Enflurane Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Enflurane Sales Value by Region (2020-2025)
5.1.3 Global Enflurane Sales Value by Region (2026-2031)
5.1.4 Global Enflurane Sales Value by Region (%), (2020-2031)
5.2 Global Enflurane Sales Volume by Region
5.2.1 Global Enflurane Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Enflurane Sales Volume by Region (2020-2025)
5.2.3 Global Enflurane Sales Volume by Region (2026-2031)
5.2.4 Global Enflurane Sales Volume by Region (%), (2020-2031)
5.3 Global Enflurane Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Enflurane Sales Value, 2020-2031
5.4.2 North America Enflurane Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Enflurane Sales Value, 2020-2031
5.5.2 Europe Enflurane Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Enflurane Sales Value, 2020-2031
5.6.2 Asia Pacific Enflurane Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Enflurane Sales Value, 2020-2031
5.7.2 South America Enflurane Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Enflurane Sales Value, 2020-2031
5.8.2 Middle East & Africa Enflurane Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Enflurane Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Enflurane Sales Value and Sales Volume
6.2.1 Key Countries/Regions Enflurane Sales Value, 2020-2031
6.2.2 Key Countries/Regions Enflurane Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Enflurane Sales Value, 2020-2031
6.3.2 United States Enflurane Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Enflurane Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Enflurane Sales Value, 2020-2031
6.4.2 Europe Enflurane Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Enflurane Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Enflurane Sales Value, 2020-2031
6.5.2 China Enflurane Sales Value by Type (%), 2024 VS 2031
6.5.3 China Enflurane Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Enflurane Sales Value, 2020-2031
6.6.2 Japan Enflurane Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Enflurane Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Enflurane Sales Value, 2020-2031
6.7.2 South Korea Enflurane Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Enflurane Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Enflurane Sales Value, 2020-2031
6.8.2 Southeast Asia Enflurane Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Enflurane Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Enflurane Sales Value, 2020-2031
6.9.2 India Enflurane Sales Value by Type (%), 2024 VS 2031
6.9.3 India Enflurane Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Company Information
7.1.2 Baxter Introduction and Business Overview
7.1.3 Baxter Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Baxter Enflurane Product Offerings
7.1.5 Baxter Recent Development
7.2 J&TEC
7.2.1 J&TEC Company Information
7.2.2 J&TEC Introduction and Business Overview
7.2.3 J&TEC Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 J&TEC Enflurane Product Offerings
7.2.5 J&TEC Recent Development
7.3 GE Healthcare
7.3.1 GE Healthcare Company Information
7.3.2 GE Healthcare Introduction and Business Overview
7.3.3 GE Healthcare Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 GE Healthcare Enflurane Product Offerings
7.3.5 GE Healthcare Recent Development
7.4 Gasera
7.4.1 Gasera Company Information
7.4.2 Gasera Introduction and Business Overview
7.4.3 Gasera Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Gasera Enflurane Product Offerings
7.4.5 Gasera Recent Development
7.5 Draeger
7.5.1 Draeger Company Information
7.5.2 Draeger Introduction and Business Overview
7.5.3 Draeger Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Draeger Enflurane Product Offerings
7.5.5 Draeger Recent Development
7.6 Abbott
7.6.1 Abbott Company Information
7.6.2 Abbott Introduction and Business Overview
7.6.3 Abbott Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Abbott Enflurane Product Offerings
7.6.5 Abbott Recent Development
7.7 AstraZeneca
7.7.1 AstraZeneca Company Information
7.7.2 AstraZeneca Introduction and Business Overview
7.7.3 AstraZeneca Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 AstraZeneca Enflurane Product Offerings
7.7.5 AstraZeneca Recent Development
7.8 Sanofi
7.8.1 Sanofi Company Information
7.8.2 Sanofi Introduction and Business Overview
7.8.3 Sanofi Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sanofi Enflurane Product Offerings
7.8.5 Sanofi Recent Development
7.9 Pfizer
7.9.1 Pfizer Company Information
7.9.2 Pfizer Introduction and Business Overview
7.9.3 Pfizer Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Pfizer Enflurane Product Offerings
7.9.5 Pfizer Recent Development
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Information
7.10.2 Johnson & Johnson Introduction and Business Overview
7.10.3 Johnson & Johnson Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Johnson & Johnson Enflurane Product Offerings
7.10.5 Johnson & Johnson Recent Development
7.11 Merck
7.11.1 Merck Company Information
7.11.2 Merck Introduction and Business Overview
7.11.3 Merck Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Merck Enflurane Product Offerings
7.11.5 Merck Recent Development
7.12 Roche
7.12.1 Roche Company Information
7.12.2 Roche Introduction and Business Overview
7.12.3 Roche Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Roche Enflurane Product Offerings
7.12.5 Roche Recent Development
7.13 Novartis
7.13.1 Novartis Company Information
7.13.2 Novartis Introduction and Business Overview
7.13.3 Novartis Enflurane Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Novartis Enflurane Product Offerings
7.13.5 Novartis Recent Development
8 Industry Chain Analysis
8.1 Enflurane Industrial Chain
8.2 Enflurane Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Enflurane Sales Model
8.5.2 Sales Channel
8.5.3 Enflurane Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Enflurane Market Trends
Table 2. Enflurane Market Drivers & Opportunity
Table 3. Enflurane Market Challenges
Table 4. Enflurane Market Restraints
Table 5. Global Enflurane Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Enflurane Revenue Market Share by Company (2020-2025)
Table 7. Global Enflurane Sales Volume by Company (2020-2025) & (MT)
Table 8. Global Enflurane Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Enflurane Price by Company (2020-2025) & (USD/MT)
Table 10. Key Manufacturers Enflurane Manufacturing Base and Headquarters
Table 11. Key Manufacturers Enflurane Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Enflurane
Table 13. Global Enflurane Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enflurane as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Enflurane Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Enflurane Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Enflurane Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Enflurane Sales Market Share in Value by Type (2020-2025)
Table 20. Global Enflurane Sales Market Share in Value by Type (2026-2031)
Table 21. Global Enflurane Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
Table 22. Global Enflurane Sales Volume by Type (2020-2025) & (MT)
Table 23. Global Enflurane Sales Volume by Type (2026-2031) & (MT)
Table 24. Global Enflurane Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Enflurane Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Enflurane Price by Type (2020-2025) & (USD/MT)
Table 27. Global Enflurane Price by Type (2026-2031) & (USD/MT)
Table 28. Global Enflurane Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Enflurane Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Enflurane Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Enflurane Sales Market Share in Value by Application (2020-2025)
Table 32. Global Enflurane Sales Market Share in Value by Application (2026-2031)
Table 33. Global Enflurane Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
Table 34. Global Enflurane Sales Volume by Application (2020-2025) & (MT)
Table 35. Global Enflurane Sales Volume by Application (2026-2031) & (MT)
Table 36. Global Enflurane Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Enflurane Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Enflurane Price by Application (2020-2025) & (USD/MT)
Table 39. Global Enflurane Price by Application (2026-2031) & (USD/MT)
Table 40. Global Enflurane Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Enflurane Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Enflurane Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Enflurane Sales Value by Region (2020-2025) & (%)
Table 44. Global Enflurane Sales Value by Region (2026-2031) & (%)
Table 45. Global Enflurane Sales Volume by Region (MT): 2020 VS 2024 VS 2031
Table 46. Global Enflurane Sales Volume by Region (2020-2025) & (MT)
Table 47. Global Enflurane Sales Volume by Region (2026-2031) & (MT)
Table 48. Global Enflurane Sales Volume by Region (2020-2025) & (%)
Table 49. Global Enflurane Sales Volume by Region (2026-2031) & (%)
Table 50. Global Enflurane Average Price by Region (2020-2025) & (USD/MT)
Table 51. Global Enflurane Average Price by Region (2026-2031) & (USD/MT)
Table 52. Key Countries/Regions Enflurane Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Enflurane Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Enflurane Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Enflurane Sales Volume, (2020-2025) & (MT)
Table 56. Key Countries/Regions Enflurane Sales Volume, (2026-2031) & (MT)
Table 57. Baxter Company Information
Table 58. Baxter Introduction and Business Overview
Table 59. Baxter Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Baxter Enflurane Product Offerings
Table 61. Baxter Recent Development
Table 62. J&TEC Company Information
Table 63. J&TEC Introduction and Business Overview
Table 64. J&TEC Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. J&TEC Enflurane Product Offerings
Table 66. J&TEC Recent Development
Table 67. GE Healthcare Company Information
Table 68. GE Healthcare Introduction and Business Overview
Table 69. GE Healthcare Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. GE Healthcare Enflurane Product Offerings
Table 71. GE Healthcare Recent Development
Table 72. Gasera Company Information
Table 73. Gasera Introduction and Business Overview
Table 74. Gasera Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Gasera Enflurane Product Offerings
Table 76. Gasera Recent Development
Table 77. Draeger Company Information
Table 78. Draeger Introduction and Business Overview
Table 79. Draeger Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Draeger Enflurane Product Offerings
Table 81. Draeger Recent Development
Table 82. Abbott Company Information
Table 83. Abbott Introduction and Business Overview
Table 84. Abbott Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Abbott Enflurane Product Offerings
Table 86. Abbott Recent Development
Table 87. AstraZeneca Company Information
Table 88. AstraZeneca Introduction and Business Overview
Table 89. AstraZeneca Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. AstraZeneca Enflurane Product Offerings
Table 91. AstraZeneca Recent Development
Table 92. Sanofi Company Information
Table 93. Sanofi Introduction and Business Overview
Table 94. Sanofi Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Sanofi Enflurane Product Offerings
Table 96. Sanofi Recent Development
Table 97. Pfizer Company Information
Table 98. Pfizer Introduction and Business Overview
Table 99. Pfizer Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Pfizer Enflurane Product Offerings
Table 101. Pfizer Recent Development
Table 102. Johnson & Johnson Company Information
Table 103. Johnson & Johnson Introduction and Business Overview
Table 104. Johnson & Johnson Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Johnson & Johnson Enflurane Product Offerings
Table 106. Johnson & Johnson Recent Development
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Merck Enflurane Product Offerings
Table 111. Merck Recent Development
Table 112. Roche Company Information
Table 113. Roche Introduction and Business Overview
Table 114. Roche Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Roche Enflurane Product Offerings
Table 116. Roche Recent Development
Table 117. Novartis Company Information
Table 118. Novartis Introduction and Business Overview
Table 119. Novartis Enflurane Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Novartis Enflurane Product Offerings
Table 121. Novartis Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Enflurane Downstream Customers
Table 125. Enflurane Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Enflurane Product Picture
Figure 2. Global Enflurane Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Enflurane Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Enflurane Sales Volume (2020-2031) & (MT)
Figure 5. Global Enflurane Sales Price (2020-2031) & (USD/MT)
Figure 6. Enflurane Report Years Considered
Figure 7. Global Enflurane Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Enflurane Players Sales Volume Ranking (2024) & (MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Enflurane Revenue in 2024
Figure 10. Enflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Pharmaceutical Grade Enflurane Picture
Figure 12. Industrial Grade Enflurane Picture
Figure 13. Global Enflurane Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Enflurane Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Enflurane Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
Figure 16. Global Enflurane Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Enflurane Price by Type (2020-2031) & (USD/MT)
Figure 18. Product Picture of Medicine
Figure 19. Product Picture of Chemical Industry
Figure 20. Product Picture of Others
Figure 21. Global Enflurane Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Enflurane Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Enflurane Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
Figure 24. Global Enflurane Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Enflurane Price by Application (2020-2031) & (USD/MT)
Figure 26. North America Enflurane Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Enflurane Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Enflurane Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Enflurane Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Enflurane Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Enflurane Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Enflurane Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Enflurane Sales Volume (%), (2020-2031)
Figure 38. United States Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Enflurane Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Enflurane Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Enflurane Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Enflurane Sales Value by Application (%), 2024 VS 2031
Figure 44. China Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Enflurane Sales Value by Type (%), 2024 VS 2031
Figure 46. China Enflurane Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Enflurane Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Enflurane Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Enflurane Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Enflurane Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Enflurane Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Enflurane Sales Value by Application (%), 2024 VS 2031
Figure 56. India Enflurane Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Enflurane Sales Value by Type (%), 2024 VS 2031
Figure 58. India Enflurane Sales Value by Application (%), 2024 VS 2031
Figure 59. Enflurane Industrial Chain
Figure 60. Enflurane Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Enflurane market?
The top companies in the global Enflurane market are Baxter、J&TEC、GE Healthcare.
Related Reports
Global Enflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Enflurane market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 94
USD 4250.00
(Single User License)
Global Enflurane Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Enflurane market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 162
USD 4900.00
(Single User License)
Enflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Enflurane was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 128
USD 3950.00
(Single User License)
Global Enflurane Market Research Report 2026
The global Enflurane market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 137
USD 2900.00
(Single User License)
Global Enflurane Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Enflurane market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 158
USD 4900.00
(Single User License)
Global Enflurane Market Insights, Forecast to 2031
The global Enflurane market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2025-06-16
Pages: 168
USD 4900.00
(Single User License)
Global Enflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enflurane market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-16
Pages: 98
USD 4250.00
(Single User License)
Global Enflurane Market Research Report 2025
The global market for Enflurane was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-06-16
Pages: 102
USD 2900.00
(Single User License)
Enflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enflurane was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 93
USD 3950.00
(Single User License)
Global Enflurane Market Insights, Forecast to 2030
Enflurane is weaker than diethyl ether, and is generally used in combination with general anesthesia, or in combination with a variety of intravenous general anesthesia and general anesthesia.
Published Date: 2024-04-19
Pages: 97
USD 4900.00
(Single User License)
Global Enflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Enflurane market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 94
USD 4250.00 (Single User License)Global Enflurane Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Enflurane market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 162
USD 4900.00 (Single User License)Enflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Enflurane was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 128
USD 3950.00 (Single User License)Global Enflurane Market Research Report 2026
The global Enflurane market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 137
USD 2900.00 (Single User License)Global Enflurane Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Enflurane market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 158
USD 4900.00 (Single User License)Global Enflurane Market Insights, Forecast to 2031
The global Enflurane market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2025-06-16
Pages: 168
USD 4900.00 (Single User License)Global Enflurane Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enflurane market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-16
Pages: 98
USD 4250.00 (Single User License)Global Enflurane Market Research Report 2025
The global market for Enflurane was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-06-16
Pages: 102
USD 2900.00 (Single User License)Enflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enflurane was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 93
USD 3950.00 (Single User License)Global Enflurane Market Insights, Forecast to 2030
Enflurane is weaker than diethyl ether, and is generally used in combination with general anesthesia, or in combination with a variety of intravenous general anesthesia and general anesthesia.
Published: 2024-04-19
Pages: 97
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now